Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.
about
Recent advances in hypertrophic cardiomyopathyClinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathyResearch priorities in sarcomeric cardiomyopathiesMyocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers2014 korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the korean society of cardiology and the korean society of radiology.Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of CareHypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.Prevalence of myocardial crypts in a large retrospective cohort study by cardiovascular magnetic resonance.Hypertrophic cardiomyopathy: infants, children, and adolescents.Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness.Sarcomere gene mutations in hypertrophy and heart failure.Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.Cardiomyopathies in childrenStructural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophyIntegrating Genetics and Medicine: Disease-Modifying Treatment Strategies for Hypertrophic Cardiomyopathy.Contemporary treatment of hypertrophic cardiomyopathyComparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.The genetics of dilated cardiomyopathy.The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophyThe development of familial hypertrophic cardiomyopathy: from mutation to bedside.Advances of cardiovascular MRI in hypertrophic cardiomyopathy.Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.The role of imaging in the diagnosis and management of hypertrophic cardiomyopathy.Evaluation of hypertrophic cardiomyopathy: new horizons for CMR?Abnormal Mitral Valve Dimensions in Pediatric Patients with Hypertrophic Cardiomyopathy.Crown years for non-invasive cardiovascular imaging (Part III): 30 years cardiovascular magnetic resonance.New Paradigms in Hypertrophic Cardiomyopathy: Insights from Genetics.An unusual presentation of a myocardial crypt in hypertrophic cardiomyopathy.Myocardial Cleft in a Patient with Acute Coronary Syndrome Assessed by Multimodal Imaging.Myocardial crypts as a preclinical sign of hypertrophic cardiomyopathy.Hypothesis and theory: mechanical instabilities and non-uniformities in hereditary sarcomere myopathies.Assessment of tenascin-C levels in ventricular noncompaction/hypertrabeculation patients: a cross-sectional study.Phenotypic diversity identified by cardiac magnetic resonance in a large hypertrophic cardiomyopathy family with a single MYH7 mutation.Cardiac MR Imaging of Hypertrophic Cardiomyopathy: Techniques, Findings, and Clinical Relevance.Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy.Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography.Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.
P2860
Q26998648-845DB14F-DE48-4064-9A1B-C716B67682A8Q26999424-5E684821-1C96-46F1-9E40-2878370310E7Q27694507-7D794C8A-62A9-4784-8303-656A0F872776Q28730121-AD82D769-E1AB-4B25-934A-398752373281Q30423759-BE627A06-2AFE-4913-BFF3-6DD5FD16C2F7Q33166450-C243AA9E-2C3D-4201-8EE2-8F9699D8C964Q33580870-279AD9DD-AAB7-4427-AF7A-E8403A6C20FBQ33741738-E10ACA0D-D23F-4FCD-9055-A0D197D1BA74Q34184953-60E2E4B1-AA97-408D-91C9-7EA33FFEDF46Q34244943-ADFD947C-66B0-444D-B70E-C8E93C3DD9ACQ34515507-D58539D6-EE5D-4C4B-BC02-01EC797963F8Q34626686-7F8E7195-13F7-4828-911C-064C846ED529Q34629550-DDCE0462-7657-42E7-BD7E-3FC0DB0014F4Q35845452-6CB9582C-4C77-49CB-B344-DF012733AEC7Q36660321-92B78E54-39CA-43D1-BCE4-ADEC4A27D51AQ36742782-07F6DAC9-0EB1-4013-9C4C-3B53BA975DEBQ36888254-2D6748B2-6EF0-4B60-9442-AB89B3522796Q37227838-0D4F3C20-5CE5-4ABB-8273-49E652ED5919Q37683177-0D7CA017-ACFA-4804-A337-0962E170E237Q37698904-8782BB69-4C83-4DA3-91E0-C24AB14AF97AQ37730496-2329F463-8009-459A-9C45-640388FB4F28Q37821051-94BA47F2-B434-4F58-BB0F-0069AEC28ABCQ38135893-53A610D8-0DF8-4D03-B693-97799FA59634Q38336102-769E284A-D6BA-4C1A-826F-D8F5FDE547EDQ38343713-2154A174-4DC2-47A4-9A17-C01B0C3340B7Q38633389-909C15AA-FC3A-4FE9-80C9-0C0B4CD64000Q39869842-751C7BEF-2F25-4BDF-8925-86E1C6F3C771Q39933386-750D78FF-BAE1-46BB-9C28-154FA7D0FCE9Q40953855-88B76900-F5BC-4D26-A9B9-107C406E40A1Q41836826-B3FECE08-D4FB-4BCF-B146-84C3B08AA7E7Q42101557-B62A9A0B-C376-42E3-AF0C-C5D029BD7B84Q42239396-A83DC650-121A-40FA-9A48-469F8ABA0CF4Q42742610-B86F1B33-B83E-4EA7-8841-28BCB7BAEDD8Q42877248-9EAE62C5-A245-4947-958F-DAD1CA57C990Q47910388-F61C3F4E-19B3-41B5-81ED-DB430E0C4637Q48223462-B2FD918D-EAEC-4336-AE48-F2CE2E2D1B36Q49989673-8C7EAC3A-08AF-4134-B4C9-C6CC31C651E2Q50623814-D518F474-97CC-4E00-9515-9F442F8DED5CQ53006905-1896D37B-F322-47FC-934A-9C4EF8F6E3B1Q53399558-664A0721-4FC3-48BC-8D1F-69C33A08ACE2
P2860
Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Structural abnormalities of th ...... phic cardiomyopathy mutations.
@en
Structural abnormalities of th ...... phic cardiomyopathy mutations.
@nl
type
label
Structural abnormalities of th ...... phic cardiomyopathy mutations.
@en
Structural abnormalities of th ...... phic cardiomyopathy mutations.
@nl
prefLabel
Structural abnormalities of th ...... phic cardiomyopathy mutations.
@en
Structural abnormalities of th ...... phic cardiomyopathy mutations.
@nl
P2093
P1476
Structural abnormalities of th ...... phic cardiomyopathy mutations.
@en
P2093
Albert C van Rossum
Pieter A Dijkmans
Tjeerd Germans
Wenxia Chai
Yigal M Pinto
P304
P356
10.1016/J.JACC.2006.08.036
P407
P577
2006-11-28T00:00:00Z